Emelife-Obi C, Chow M T, Qamar-Rohail H, Leehey D J, Gandhi V C, Ing T S
Department of Medicine, Veterans Affairs Hospital, Hines, Illinois 60141, USA.
Clin Nephrol. 1998 Aug;50(2):131-3.
We describe a patient who suffered from renal failure-associated pericarditis and underwent daily 3.5-hour hemodialysis treatments for 17 days. The initially elevated serum phosphorus level gradually fell to below normal on days 11 and 12 as a result of the intensive dialytic therapy. Phosphorus was added to the "base concentrate" of a dual-concentrate, bicarbonate-based dialysate delivery system on days 13 to 17. Because of this phosphorus-enrichment, we were able to maintain the patient's serum phosphorus levels within normal limits in spite of continued daily dialysis treatments.
我们描述了一名患有肾衰竭相关性心包炎的患者，该患者接受了为期17天的每日3.5小时血液透析治疗。由于强化透析治疗，最初升高的血清磷水平在第11天和第12天逐渐降至正常水平以下。在第13天至17天，将磷添加到双浓缩、基于碳酸氢盐的透析液输送系统的“基础浓缩液”中。由于这种磷富集，尽管持续进行每日透析治疗，我们仍能够将患者的血清磷水平维持在正常范围内。
